Another study showed that rehmannioside A can improve cognitive impairment after ischemic stroke, which may be related to inhibition of neuroptosis and activation of the PI3K/AKT/Nrf2 pathway [112]. This evidence concerns the gene AKT1 and ischemic stroke.